|
Article Excerpt
Business Editors/Health/Medical Writers
BIOWIRE2K
MIRAMAR, Fla.--(BUSINESS WIRE)--July 3, 2003
Nitto Americas, Inc., the U.S. subsidiary of Nitto Denko, has agreed to acquire 100% of the stock of Elan Transdermal Technologies, Inc. ("ETT"), a wholly-owned subsidiary of Elan Corporation, plc (NYSE:ELN), a fully integrated biopharmaceutical company headquartered in Dublin, Ireland.
ETT is a fully-integrated transdermal research, development and manufacturing company that offers proprietary and generic controlled-release transdermal products for a wide range of therapies, utilizing a number...
|
|
More articles from Business Wire
NetEase.com Enters into Agreement With Affiliates of The News Corporat..., July 04, 2003
Auto Club: Gas Prices Continue Slow Slide., July 04, 2003
REMINDER/Best Buy Presents Fourth of July Concert by the Minnesota Jaz..., July 04, 2003
S&P Asgns Prl Rtgs to Delphinus Capital Japanese ABS., July 04, 2003
S&P Global Credit Markets Digest-Asia-Pacific Update., July 04, 2003
Looking for additional articles?
Search our database of over 3 million articles.
Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication
name or publication date.
About Goliath
Whether you're looking for sales prospects, competitive information, company
analysis or best practices in managing your organization,
Goliath can help you meet your business needs.
Our extensive business information databases empower business
professionals with both the breadth and depth of credible,
authoritative information they need to support their business
goals. Whether it be strategic planning, sales prospecting,
company research or defining management best practices -
Goliath is your leading source for accurate information.
|
|
